Clinical Trial Update: Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis [NA]

View source ↗

Summary

Clinical trial update notes Rituximab as a treatment option being studied for new-onset acetylcholine receptor antibody-positive myasthenia gravis; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Tang-Du Hospital | Conditions: Treatment | NA | Status: ACTIVE_NOT_RECRUITING